Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

COI Affiliated Publications (First author/ Corresponding author)

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Journal article

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

Time of Day of Vaccination Affects SARS-CoV-2 Antibody Responses in an Observational Study of Health Care Workers

Journal article

Wang W. et al, (2021), Journal of Biological Rhythms, 074873042110593 - 074873042110593

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.

Journal article

Dejnirattisai W. et al, (2021), Lancet (London, England)

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants.

Journal article

Liu C. et al, (2022), Cell host & microbe, 30, 53 - 68.e12

The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

Journal article

de Silva TI. et al, (2021), iScience, 24, 103353 - 103353

Priority index: database of genetic targets in immune-mediated disease.

Journal article

Fang H. and Knight JC., (2021), Nucleic Acids Res

Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2

Journal article

Wellington D. et al, (2021), Current Opinion in Virology, 50, 183 - 191

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Journal article

Feng S. et al, (2021), Nature Medicine, 27, 2032 - 2040

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum

Journal article

Liu C. et al, (2021), Cell, 184, 4220 - 4236.e13

Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells

Journal article

Wing PAC. et al, (2021), Cell Reports, 35, 109020 - 109020

Antibody evasion by the P.1 strain of SARS-CoV-2

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Journal article

Townsend A. et al, (2021), Nature Communications, 12

Host genetics and infectious disease: new tools, insights and translational opportunities

Journal article

Kwok AJ. et al, (2020), Nature Reviews Genetics

IFITM3-specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans.

Journal article

Wellington D. et al, (2021), European journal of immunology, 51, 742 - 745

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Journal article

Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Journal article

Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6

DUB esterase activity further decodes ubiquitin’s enigma

Journal article

Kessler BM., (2021), Proceedings of the National Academy of Sciences, 118, e2026389118 - e2026389118

Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.

Journal article

Pinto-Fernandez A. et al, (2020), British journal of cancer

Clocks, Viruses, and Immunity: Lessons for the COVID-19 Pandemic.

Journal article

Sengupta S. et al, (2021), Journal of biological rhythms, 36, 23 - 34

Malignancy and IFITM3: Friend or Foe?

Journal article

Rajapaksa US. et al, (2020), Frontiers in oncology, 10

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

Journal article

Zhou D. et al, (2020), Nature Structural & Molecular Biology, 27, 950 - 958

Human cancer germline antigen-specific cytotoxic T cell-what can we learn from patient.

Journal article

Abd Hamid M. et al, (2020), Cellular & molecular immunology

A Novel Scoring System for Prediction of Disease Severity in COVID-19.

Journal article

Zhang C. et al, (2020), Frontiers in cellular and infection microbiology, 10

Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses

Journal article

Abd Hamid M. et al, (2020), Cancer Immunology Research, 8, 203 - 216

Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses

Journal article

Abd Hamid M. et al, (2019), Cancer Immunology Research, 7, 1293 - 1306

IFITM3: How genetics influence influenza infection demographically.

Journal article

Wellington D. et al, (2019), Biomedical journal, 42, 19 - 26

COI Affiliated Publications (non-first author/ corresponding author)

Why do breakthrough COVID-19 infections occur in the vaccinated?

Journal article

Maclean P. et al, (2021), QJM : monthly journal of the Association of Physicians

HIF1α-mediated RelB/APOBEC3B downregulation allows Hepatitis B Virus persistence.

Journal article

Riedl T. et al, (2021), Hepatology (Baltimore, Md.)

Promises and challenges of adoptive T-cell therapies for solid tumours

Journal article

AHMED A. et al, (2021), British Journal of Cancer

Native-like SARS-CoV-2 Spike Glycoprotein Expressed by ChAdOx1 nCoV-19/AZD1222 Vaccine.

Journal article

Watanabe Y. et al, (2021), ACS central science, 7, 594 - 602

Defactinib inhibits PYK2 phosphorylation of IRF5 and reduces intestinal inflammation

Journal article

Berthold D., (2021), Nature Communications

Supramolecular Cylinders Target Bulge Structures in the 5' UTR of the RNA Genome of SARS-CoV-2 and Inhibit Viral Replication*.

Journal article

Melidis L. et al, (2021), Angewandte Chemie (International ed. in English), 60, 18144 - 18151

Reactivation of a developmentally silenced embryonic globin gene.

Journal article

King AJ. et al, (2021), Nat Commun, 12

Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation

Journal article

Asciak R. et al, (2021), Frontiers in Oncology, 11

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison

Journal article

Ainsworth M. et al, (2020), The Lancet Infectious Diseases, 20, 1390 - 1400

Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments

Journal article

Kanellakis NI. et al, (2020), Thorax, 75, 1004 - 1008

Ubiquitomics: An Overview and Future

Journal article

Vere G. et al, (2020), Biomolecules, 10, 1453 - 1453

Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Journal article

Huo J. et al, (2020), Nature Structural & Molecular Biology, 27, 846 - 854

Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike

Journal article

Huo J. et al, (2020), Cell Host & Microbe, 28, 445 - 454.e6

Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.

Journal article

Song R. et al, (2020), The Journal of Infection

Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.

Journal article

Kanellakis NI. et al, (2019), BMJ open respiratory research, 6

COI Affiliated Publications—Preprints (first/corresponding author)